- Home
- XFOR vs ZH Comparison
XFOR vs ZH Comparison
Compare XFOR & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XFOR | ZH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.5M | 264.5M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XFOR | ZH |
|---|---|---|
| Price | $3.15 | $2.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $11.60 | $4.09 |
| AVG Volume (30 Days) | ★ 646.1K | 277.9K |
| Earning Date | 11-04-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | ★ 150.00 | N/A |
| 52 Week Low | $2.43 | $2.55 |
| 52 Week High | $4.83 | $4.52 |
Technical Indicators
Market Signals| Indicator | XFOR | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 33.10 |
| Support Level | $2.83 | $2.57 |
| Resistance Level | $3.52 | $3.42 |
| Average True Range (ATR) | 0.26 | 0.20 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 53.47 | 17.86 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is engaged in the operation of one online content community which monetizes through paid membership services, marketing services and other services in the People's Republic of China. It is an online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Its community supports discussions ranging from everyday consumer decisions, such as purchasing products or planning travel, to more specialized areas on professional knowledge, technological developments including artificial intelligence and academic topics. It operates in single segment and its revenues are derived from within the PRC.